ʻO Glecaprevir a me Pibrentasvir

Anter

• Ma mua o ka lawe ʻana i glecaprevir a me pibrentasvir,
• Hiki i ka Glecaprevir a me ka pibrentasvir ke hana i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• ʻO Glecaprevir a me pibrentasvir ke kumu o nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Ua hele a maʻi paha ʻoe i ka maʻi hepatitis B (kahi maʻi i hoʻopili ʻia i ke akepaʻa a e hōʻeha paha i ka ate) akā ʻaʻohe o nā ʻōuli o ka maʻi. I kēia hihia, lawe i ka hui ʻana o glecaprevir a me pibrentasvir e hoʻonui i ka makaʻu e lilo i kou maʻi a ʻoi aku ka hoʻoweliweli a e hoʻomohala ʻoe i nā ʻōuli. E haʻi i kāu kauka inā loaʻa a loaʻa paha iā ʻoe i ka maʻi maʻi maʻi hepatitis B. E kauoha aku kāu kauka i kahi hoʻokolohua koko e ʻike inā loaʻa a loaʻa paha iā ʻoe i ka maʻi hepitis B. E nānā pū kāu kauka iā ʻoe no nā hōʻailona o ka maʻi hepatitis B i ka manawa a no kekahi mau mahina ma hope o kāu lapaʻau. Inā pono, hiki i kāu kauka ke hāʻawi iā ʻoe i ka lāʻau e mālama ai i kēia maʻi ma mua a i kou wā o ka mālama ʻana me ka hui ʻana o glecaprevir a me pibrentasvir. Inā ʻoe e ʻike i kekahi o nā ʻōuli ma hope a i ʻole a ma hope paha o kāu lapaʻau ʻana, kāhea koke aku i kāu kauka: luhi nui, melemele o ka ʻili a i ʻole nā ​​maka, nalo ʻole ka makemake, kahoʻi, ka luaʻi, nā pale pale, ʻeha ma ka ʻaoʻao ʻākau o ka ʻōpū ma luna, aiʻole mimi ʻeleʻele.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. Hiki i kāu kauka ke kauoha i kekahi mau hoʻokolohua ma mua, i ka wā, a ma hope o kāu mālama ʻana e nānā i ka pane o kou kino i ka hui pū ʻana o glecaprevir a me pibrentasvir.

E kamaʻilio me kāu kauka e pili ana i nā pilikia o ka lawe glecaprevir a me pibrentasvir.

Hoʻohana ʻia ka laulima o glecaprevir a me pibrentasvir e mālama ai i kekahi ʻano o ka maʻi hepatitis C mau loa (wā lōʻihi) (ka pehu ʻana o ke akepaʻa i hoʻokumu ʻia e kahi maʻi) i nā mākua a me nā keiki he 12 mau makahiki a ʻoi paha ke kaupaona ma kahi o 99 paona (45 kilokilo). Hoʻohana ʻia ia e mālama i kekahi ʻano o ka maʻi hepatitis C mau loa i nā mākua a me nā keiki he 12 mau makahiki a ʻoi paha ke kaupaona ma kahi o 99 paona (45 kilokilo) i loaʻa i nā lāʻau hou e mālama ai i ko lākou maʻi hepitis C. Aia ʻo Glecaprevir i kahi papa o nā lāʻau i kapa ʻia ʻo HCV NS3 / 4A protease inhibitors. Hana ia ma ka hoʻemi ʻana i ka nui o ka maʻi hepitis C (HCV) i ke kino. Aia ʻo Pibrentasvir i kahi papa o nā lāʻau i kapa ʻia ʻo nā mea kūpale HCV NS5A. Hana ia ma ka hoʻōki ʻana i ka maʻi hoʻomaʻemaʻe ke kumu e pāhola aku ai ka maʻi hepatitis C i loko o ke kino.

ʻO ka hui pū ʻana o glecaprevir a me pibrentasvir e hele mai ana ma ke ʻano he papa e lawe ʻia e ka waha. Lawe ʻia ia me ka meaʻai hoʻokahi manawa i kēlā me kēia lā no 8 a 16 mau pule. Lawe i ka glecaprevir a me ka pibrentasvir ma kahi o ka manawa like i kēlā me kēia lā. E hāhai pono i nā ʻōkuhi i kāu lepili kuhikuhi, a nīnau i kāu kauka a kauka paha e wehewehe i kahi ʻāpana āu i maopopo ʻole ai. Lawe i ka glecaprevir a me ka pibrentasvir e like me ke kuhikuhi. Mai lawe i ka mea ʻoi aku a liʻiliʻi paha o ia mea a lawe pinepine iā ia ma mua o ka mea i kauoha ʻia e kāu kauka.

E hoʻomau i ka lawe ʻana i ka glecaprevir a me ka pibrentasvir ʻoiai inā ʻoluʻolu ʻoe. Aia ka lōʻihi o kāu lapaʻau i kāu kūlana, inā ua lawe mua ʻoe i kekahi mau lāʻau HCV, pehea kou pane maikaʻi ʻana i ka lāʻau, a inā paha ʻoe e ʻike i nā hopena ʻino. Mai hooki i ka lawe ʻana i ka glecaprevir a me ka pibrentasvir me ke kamaʻilio ʻole ʻana me kāu kauka.

E noi i kāu kauka lāʻau a kauka paha no kahi kope o ka ʻike a ka mea hana no ka mea maʻi.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka lawe ʻana i glecaprevir a me pibrentasvir,

• e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka glecaprevir, pibrentasvir, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i loko o ka papa glecaprevir a me pibrentasvir. E noi i kāu kauka lāʻau no kahi papa inoa o nā mea hoʻohui.
• E haʻi i kāu kauka inā lawe ʻoe i atazanavir (Reyataz, ma Evotaz) a i ʻole rifampin (Rifadin, Rimactane, ma Rifamate, ma Rifater). E haʻi paha kāu kauka iā ʻoe ʻaʻole e lawe i ka glecaprevir a me ka pibrentasvir inā ʻoe e lawe i kekahi o kēia mau lāʻau.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. E hōʻoia e haʻi i kekahi o kēia mau mea: anticoagulants ('nā mea hōʻemi koko') e like me warfarin (Coumadin, Jantoven); carbamazepine (Carbatrol, Epitol, Equetro, Tegretol), nā lāʻau hoʻohaʻahaʻa kolesterol (statins) e like me atorvastatin (Lipitor, ma Caduet), fluvastatin (Lescol), lovastatin (Altoprev), pitavastatin (Livalo), pravastatin (Pravachol), rosuvastatin ( Crestor), a me simvastatin (Zocor, ma Simcor, ma Vytorin); cyclosporine (Gengraf, Neoral, Sandimmune); dabigatran (Pradaxa); digoxin (Lanoxin); ethinyl estradiol oral contraceptives e like me kekahi ('pills kaohi hānau'), nā pākuʻi, nā apo heele hormonal, a me nā huahana ethinyl estradiol ʻē aʻe; kekahi o nā mea hoʻōla hormonone (HRT); a me kekahi mau lāʻau no ka maʻi pale maʻi (HIV) a i ʻole loaʻa i ka maʻi maʻi maʻi maʻi (AIDS) me darunavir (Prezista, i Prezcobix), efavirenz (Sustiva, i Atripla), lopinavir (i Kaletra), a i ʻole ritonavir (Norvir, i Kaletra); a me phenytoin (Dilantin, Phenytek). Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka i nā huahana lāʻau āu e lawe nei, ʻo ka wort ʻo St.
• e haʻi i kāu kauka inā loaʻa kekahi ʻano maʻi maʻi akepē aʻe ma mua o ka maʻi hepitis C. E haʻi paha kāu kauka iā ʻoe ʻaʻole e lawe i ka glecaprevir a me ka pibrentasvir.
• e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole loaʻa iā ʻoe i kahi maʻi pale maʻi (HIV) a i ʻole diabetes, a inā i loaʻa iā ʻoe kahi ake a me nā puʻuwai.
• E haʻi i kāu kauka inā hāpai ʻoe, e hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka lawe ʻana i glecaprevir a me pibrentasvir, e kāhea i kāu kauka.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā he 18 mau hola a ʻoi iki paha ma hope o kou nalo ʻana i kahi mahele o glecaprevir a me pibrentasvir, e lawe i ka lāʻau i hala me ka meaʻai ke hoʻomanaʻo koke ʻoe iā ia. Eia nō naʻe, inā ʻoi aku ia ma mua o 18 mau hola mai ka manawa āu e lawe ai i kāu lāʻau, e lele i ka lāʻau i hala a hoʻomau i kāu papa hana maʻamau. Mai lawe i kahi lāʻau pālua e pani no kahi mea i hala.

Hiki i ka Glecaprevir a me ka pibrentasvir ke hana i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• ʻeha poʻo
• luhi
• nāwaliwali
• nausea
• pāhoehoe
• ʻūlili

ʻO Glecaprevir a me pibrentasvir ke kumu o nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

• hiamoe
• huikau
• pehu o ka ʻōpū wahi
• luaʻi i ke koko a i ʻole mea e like me nā papa kope
• ʻūlū pouli, ʻeleʻele, a i ʻole ke koko

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pahu i komo ai, pani paʻa ʻia, a ʻaʻole hiki i nā kamaliʻi. E mālama iā ia i ka mahana wela o ka lumi a ma kahi o ka wela a me ka momona (ʻaʻole i ka lua.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Mai ʻae i kahi mea ʻē aʻe e lawe i kāu lāʻau. E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka hoʻopiha hou ʻana i kāu kuhikuhi.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Mavyret^®